Functions and inhibition of BET bromodomains in pathogenic fungi

被引：0
|
作者：
Sayou, Camille [1 ]
Govin, Jérôme [1 ]
机构：
[1] Inserm U1209, CNRS UMR 5309, Univ. Grenoble Alpes, Institute for Advanced Biosciences, Grenoble, France
来源：
Current Opinion in Green and Sustainable Chemistry | 2022年 / 34卷
关键词：
Antifungals - BET protein - Biological functions - Bromodomain - Chromatin - Drug compounds - Fungal infection - Fungal pathogen - Pathogenic fungi - Protein family;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Invasive fungal infections are a major public health problem. While therapeutic options remain very limited, new antifungal strategies are urgently needed. Bromodomains (BDs) of the BET protein family are chromatin-interacting modules with important biological functions. Human BET BDs can be inhibited by drug compounds, with clinical potential in oncology and inflammatory diseases. Here we review current knowledge of fungal BET BDs. We list their roles in chromatin signalling and present recent evidence for their selective inhibition. Finally, we discuss the possibility of using fungal BET BDs as therapeutic targets for future antifungal drug development. © 2022 Elsevier B.V.
引用
收藏
相关论文
共 50 条
  • [41] Inhibition of growth of fungi pathogenic to man by Stenotrophomonas maltophilia
    Kerr, JR
    JOURNAL OF MEDICAL MICROBIOLOGY, 1996, 45 (05) : 380 - 382
  • [42] Decreased Proliferation of vascular Smooth Muscle Cells and Prevention of Neointima Formation due to Vasodilation through Inhibition of BET Bromodomains
    Haertle, M.
    Dutzmann, J.
    Daniel, J.
    Donde, K.
    Bauersachs, J.
    Weisheit, S.
    Sedding, D.
    INTERNIST, 2015, 56 : 67 - 67
  • [43] Hyperproliferation Of Airway Smooth Muscle Cells In COPD Is Dependent On Bet Bromodomains
    Perry, M. M.
    Adcock, I. M.
    Chung, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [44] Bromodomains: Structure, function and pharmacology of inhibition
    Ferri, Elena
    Petosa, Carlo
    McKenna, Charles E.
    BIOCHEMICAL PHARMACOLOGY, 2016, 106 : 1 - 18
  • [45] Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family
    Filippakopoulos, Panagis
    Picaud, Sarah
    Fedorov, Oleg
    Keller, Marco
    Wrobel, Matthias
    Morgenstern, Olaf
    Bracher, Franz
    Knapp, Stefan
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (06) : 1878 - 1886
  • [46] Structure-Guided Design of Potent Diazobenzene Inhibitors for the BET Bromodomains
    Zhang, Guangtao
    Plotnikov, Alexander N.
    Rusinova, Elena
    Shen, Tong
    Morohashi, Keita
    Joshua, Jennifer
    Zeng, Lei
    Mujtaba, Shiraz
    Ohlmeyer, Michael
    Zhou, Ming-Ming
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (22) : 9251 - 9264
  • [47] Profiling the regulatory interplay of BET bromodomains and Sirtuins in cancer cell lines
    Jarvenpaa, Joni
    Rahnasto-Rilla, Minna
    Lahtela-Kakkonen, Maija
    Kublbeck, Jenni
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 147
  • [48] Targeting BET Bromodomains in Pre-Clinical Models of Burkitt Lymphoma
    Ippolito, Thomas
    Gu, Juan J.
    Tang, Gregory
    Mavis, Cory
    Miles, Rodney R.
    Hernandez-Ilizaliturri, Francisco J.
    Barth, Matthew J.
    BLOOD, 2016, 128 (22)
  • [49] Development of a first in class inhibitor of BET bromodomains and dopamine receptor 2
    Yoshioka, Makoto
    Chauhan, Jay
    Fletcher, Steven
    Strovel, Jeffrey W.
    CANCER RESEARCH, 2017, 77
  • [50] Growth inhibition of plant pathogenic fungi by hydroxy fatty acids
    Hou, CT
    Forman, RJ
    JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY, 2000, 24 (04) : 275 - 276
12345